About Canostix
Canostix is developing a blood-based cancer test that combines photonics and pattern recognition, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines. Currently, we are raising funds to extend our proof-of-concept together with our renowned partners in India, fast-tracking clinical translation. Our goal is to introduce an affordable cancer test at the GP level that gives people certainty and enables them to act for a better quality of life.
- Founding: 2018
- Focus : Manufacturer
- Employees: 1-10
- Industry : Diagnostics
Advertisement
Product portfolio of Canostix
Here you will find Canostix
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.